A detailed history of Bell Investment Advisors, Inc transactions in Pfizer Inc stock. As of the latest transaction made, Bell Investment Advisors, Inc holds 4,282 shares of PFE stock, worth $114,415. This represents 0.02% of its overall portfolio holdings.

Number of Shares
4,282
Previous 5,629 23.93%
Holding current value
$114,415
Previous $157,000 21.66%
% of portfolio
0.02%
Previous 0.03%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$27.7 - $31.39 $37,311 - $42,282
-1,347 Reduced 23.93%
4,282 $123,000
Q2 2024

Aug 07, 2024

BUY
$25.26 - $29.6 $3,460 - $4,055
137 Added 2.49%
5,629 $157,000
Q1 2024

May 08, 2024

SELL
$25.89 - $29.73 $12,064 - $13,854
-466 Reduced 7.82%
5,492 $152,000
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $12,986 - $16,868
497 Added 9.1%
5,958 $171,000
Q3 2023

Nov 08, 2023

BUY
$32.09 - $37.51 $97,489 - $113,955
3,038 Added 125.38%
5,461 $181,000
Q2 2023

Aug 09, 2023

BUY
$36.12 - $41.79 $9,174 - $10,614
254 Added 11.71%
2,423 $88,000
Q1 2023

May 10, 2023

SELL
$39.39 - $51.28 $31,039 - $40,408
-788 Reduced 26.65%
2,169 $88,000
Q4 2022

Feb 08, 2023

BUY
$41.75 - $54.5 $40,038 - $52,265
959 Added 48.0%
2,957 $151,000
Q3 2022

Nov 09, 2022

BUY
$43.76 - $53.42 $9,102 - $11,111
208 Added 11.62%
1,998 $87,000
Q2 2022

Aug 12, 2022

BUY
$46.53 - $55.17 $4,978 - $5,903
107 Added 6.36%
1,790 $94,000
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $7,561 - $11,208
183 Added 12.2%
1,683 $99,000
Q3 2021

Nov 12, 2021

BUY
$39.25 - $50.42 $58,875 - $75,630
1,500 New
1,500 $65,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Bell Investment Advisors, Inc Portfolio

Follow Bell Investment Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bell Investment Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bell Investment Advisors, Inc with notifications on news.